5-Fluorouracil: mechanisms of action and clinical strategies (Q28201937)

title

5-fluorouracil: mechanisms of action and clinical strategies (English)

0 references

5-Fluorouracil: mechanisms of action and clinical strategies (English)

1 reference

29 December 2023

1 reference

Daniel B. Longley

1

1 reference

PubMed ID

12724731

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12724731

29 December 2023

D. Paul Harkin

series ordinal

2

1 reference

PubMed ID

12724731

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12724731

29 December 2023

Patrick G. Johnston

series ordinal

3

1 reference

PubMed ID

12724731

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12724731

full work available at URL

29 December 2023

language of work or name

English

0 references

publication date

May 2003

0 references

http://www.nature.com/articles/nrc1074

1 reference

http://www.nature.com/articles/nrc1074.pdf

29 December 2023

file format

Portable Document Format

1 reference

Capecitabine: a novel agent for the treatment of solid tumors

29 December 2023

published in

Nature Reviews Cancer

0 references

volume

3

0 references

page(s)

330-8

0 references

issue

5

0 references

cites work

1 reference

Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer

31 March 2020

1 reference

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

31 March 2020

1 reference

Facilitated transport of uracil and 5-fluorouracil, and permeation of orotic acid into cultured mammalian cells

31 March 2020

1 reference

Clinical pharmacology of 5-fluorouracil

31 March 2020

1 reference

Purification and amino acid analysis of an active site peptide from thymidylate synthetase containing covalently bound 5-fluoro-2'-deoxyuridylate and methylenetetrahydrofolate.

31 March 2020

1 reference

Mechanism of interaction of thymidylate synthetase with 5-fluorodeoxyuridylate.

31 March 2020

1 reference

Immunoreactive dUMP and TTP pools as an index of thymidylate synthase inhibition; effect of tomudex (ZD1694) and a nonpolyglutamated quinazoline antifolate (CB30900) in L1210 mouse leukaemia cells

31 March 2020

1 reference

Biochemical effects of folate-based inhibitors of thymidylate synthase in MGH-U1 cells

31 March 2020

1 reference

An N -Glycosidase from Escherichia coli That Releases Free Uracil from DNA Containing Deaminated Cytosine Residues

31 March 2020

1 reference

Deoxyuridine triphosphatase (dUTPase) expression and sensitivity to the thymidylate synthase (TS) inhibitor ZD9331

31 March 2020

1 reference

The role of dUTPase and uracil-DNA repair in cancer chemotherapy

31 March 2020

1 reference

Enhancement of 5-fluorouracil's anticancer activity by dipyridamole

31 March 2020

1 reference

The inhibitory effects of 5-fluorouracil on the metabolism of preribosomal and ribosomal RNA in L-1210 cells in vitro

31 March 2020

1 reference

Catalytic mechanism and inhibition of tRNA (uracil-5-)methyltransferase: evidence for covalent catalysis

31 March 2020

1 reference

Ribonucleoprotein particle assembly and modification of U2 small nuclear RNA containing 5-fluorouridine

31 March 2020

1 reference

Interactions of transfer RNA pseudouridine synthases with RNAs substituted with fluorouracil

31 March 2020

1 reference

Enhancement of fluorinated pyrimidine-induced cytotoxicity by leucovorin in human colorectal carcinoma cell lines

31 March 2020

1 reference

Effect of polyglutamylation of 5,10-methylenetetrahydrofolate on the binding of 5-fluoro-2'-deoxyuridylate to thymidylate synthase purified from a human colon adenocarcinoma xenograft

31 March 2020

1 reference

Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project

31 March 2020

1 reference

A review of the pharmacology and clinical activity of new chemotherapy agents for the treatment of colorectal cancer

31 March 2020

1 reference

Multicenter phase III study of uracil/tegafur and oral leucovorin versus fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer

31 March 2020

1 reference

Antitumor activity and low intestinal toxicity of S-1, a new formulation of oral tegafur, in experimental tumor models in rats

31 March 2020

1 reference

Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue

31 March 2020

1 reference

Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients

31 March 2020

1 reference

Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study

31 March 2020

1 reference

Enhanced 5-fluorouracil cytotoxicity and elevated 5-fluoronucleotides in the rat Walker carcinosarcoma following methotrexate pre-treatment: a 19F-MRS study in vivo

31 March 2020

1 reference

Inhibition by methotrexate of the stable incorporation of 5-fluorouracil into murine bone marrow DNA

31 March 2020

1 reference

Meta-analysis of randomized trials testing the biochemical modulation of fluorouracil by methotrexate in metastatic colorectal cancer. Advanced Colorectal Cancer Meta-Analysis Project

31 March 2020

1 reference

Cytokines induce uridine phosphorylase in mouse colon 26 carcinoma cells and make the cells more susceptible to 5'-deoxy-5-fluorouridine.

31 March 2020

1 reference

Cytokines induce thymidine phosphorylase expression in tumor cells and make them more susceptible to 5'-deoxy-5-fluorouridine

31 March 2020

1 reference

Phase II trial of fluorouracil and recombinant interferon alfa-2a in patients with advanced colorectal carcinoma: an Eastern Cooperative Oncology Group study

31 March 2020

1 reference

Phase II study of fluorouracil, leucovorin, and interferon alfa-2a in metastatic colorectal carcinoma

31 March 2020

1 reference

Adjuvant 5-fluorouracil and leucovorin with or without interferon alfa-2a in colon carcinoma: National Surgical Adjuvant Breast and Bowel Project protocol C-05.

31 March 2020

1 reference

Randomized trial assessing the addition of interferon alpha-2a to fluorouracil and leucovorin in advanced colorectal cancer. Colorectal Cancer Working Party of the United Kingdom Medical Research Council.

31 March 2020

1 reference

Phase III randomized study to compare interferon alfa-2a in combination with fluorouracil versus fluorouracil alone in patients with advanced colorectal cancer

31 March 2020

1 reference

Thymidylate synthase gene amplification in human colon cancer cell lines resistant to 5-fluorouracil

31 March 2020

1 reference

Immunohistochemical determination of thymidylate synthase in colorectal cancer--methodological studies

31 March 2020

1 reference

Thymidylate synthase pharmacogenetics in colorectal cancer

31 March 2020

1 reference

Functional analysis and DNA polymorphism of the tandemly repeated sequences in the 5'-terminal regulatory region of the human gene for thymidylate synthase

31 March 2020

1 reference

Thymidylate synthase gene polymorphism determines response and toxicity of 5-FU chemotherapy

31 March 2020

1 reference

Fluorouracil and high-dose leucovorin in previously treated patients with metastatic breast cancer.

31 March 2020

1 reference

Identification of a thymidylate synthase ribonucleoprotein complex in human colon cancer cells

31 March 2020

1 reference

Increased cytotoxicity and bystander effect of 5-fluorouracil and 5-deoxy-5-fluorouridine in human colorectal cancer cells transfected with thymidine phosphorylase

31 March 2020

1 reference

Clinicopathologic and prognostic significance of an angiogenic factor, thymidine phosphorylase, in human colorectal carcinoma

31 March 2020

1 reference

Retroviral transduction of human dihydropyrimidine dehydrogenase cDNA confers resistance to 5-fluorouracil in murine hematopoietic progenitor cells and human CD34+-enriched peripheral blood progenitor cells

31 March 2020

1 reference

Cancer. p53, guardian of the genome

31 March 2020

1 reference

Tumor suppressor p53 can participate in transcriptional induction of the GADD45 promoter in the absence of direct DNA binding

31 March 2020

1 reference

Disruption of p53 in human cancer cells alters the responses to therapeutic agents

31 March 2020

1 reference

Role of BAX in the apoptotic response to anticancer agents

31 March 2020

1 reference

P53 overexpression predicts poor chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV colorectal cancers after palliative bowel resection

31 March 2020

1 reference

Thymidilate synthase and p53 primary tumour expression as predictive factors for advanced colorectal cancer patients

31 March 2020

1 reference

The p53 gene in breast cancer: prognostic value of complementary DNA sequencing versus immunohistochemistry

31 March 2020

1 reference

Analysis of mismatch repair genes in hereditary non–polyposis colorectal cancer patients

31 March 2020

1 reference

Microsatellite instability in human cancer: a prognostic marker for chemotherapy?

31 March 2020

1 reference

DNA mismatch repair defects: role in colorectal carcinogenesis

31 March 2020

1 reference

A gene expression database for the molecular pharmacology of cancer

31 March 2020

1 reference

Fas ligand-induced apoptosis

31 March 2020

1 reference

Thymineless death in colon carcinoma cells is mediated via fas signaling

31 March 2020

1 reference

Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer

31 March 2020

1 reference

Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group

31 March 2020

1 reference

31 March 2020

1

14

119

RJ Rutman

1954

1 reference

29 December 2023

Molecular Pharmacology

20

21

468

RI Glazer

1982

1 reference

29 December 2023

22

54

632

K Ghoshal

1994

1 reference

29 December 2023

28

39

3694

CK Carrico

1979

1 reference

29 December 2023

29

50

3262

LH Matherly

1990

1 reference

29 December 2023

32

49

2592

JE Wright

1989

1 reference

29 December 2023

40

55

1239

T Spector

1995

1 reference

29 December 2023

42

62

2313

D Cao

2002

1 reference

29 December 2023

46

42

2081

C Benz

1982

1 reference

29 December 2023

Cancer Treatment Reports

51

70

219

B Leyland-Jones

1986

1 reference

29 December 2023

53

53

4243

JA Houghton

1993

1 reference

29 December 2023

Molecular Pharmacology

56

43

527

E Chu

1993

1 reference

29 December 2023

62

52

4306

PG Johnston

1992

1 reference

29 December 2023

65

55

1407

PG Johnston

1995

1 reference

Biochimica et Biophysica Acta

29 December 2023

82

1471

M43

GP Dotto

2000

1 reference

29 December 2023

87

62

2644

DB Longley

2002

1 reference

29 December 2023

91

58

1149

DJ Ahnen

1998

1 reference

29 December 2023

97

61

5193

M Meyers

2001

1 reference

29 December 2023

98

62

518

H Zembutsu

2002

1 reference

29 December 2023

100

61

6474

C Kihara

2001

1 reference

29 December 2023

105

61

5505

W Wang

2001

1 reference

29 December 2023

Identifiers

DOI

10.1038/NRC1074

1 reference

Consolidated OpenCitations Corpus – April 2017

Dimensions Publication ID

372330

1012947440

0 references

372330

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference